The world has more promising discovered drug candidates than ever. The problem is developing them. We built Formation Bio to fix that, using AI to develop drugs faster and with a higher likelihood of success.
Thank you @amyfeldman and @Forbes telling the story of our mission, and our vision for the future of pharma.
https://t.co/OPzWSWqlIL
In just one year, $7.7B was spent on clinical trials that were ultimately terminated. Better trial prediction could change that. Delphi, our multi-agent clinical trial prediction system, surfaces probability of success predictions backed by extensive evidence and reasoning. Read more about Delphi here: https://t.co/wllwiRYUiQ
Last week, we gathered the AI & Biotech community up and at ‘em early in Boston for a 5K run followed by breakfast. New York is next – join us for a 5K run, breakfast at our office, and conversations with our teams who are building AI for drug development. Link to register: https://t.co/ia6pKd3sIU
Raising the standard of care for patients means delivering treatments that are safer, more effective, or better suited to specific patient needs than what's already available.
Here’s how we built a flexible intelligence framework to structure clinical data, visualize efficacy-safety tradeoffs, and define success at scale: https://t.co/yBDoYNCtyR
90+ non-engineers. One week. A working AI app each.
At Formation Bio, building with AI is a baseline expectation for everyone. Ops, clinicians, HR, marketing – everyone. Real tools, shipped, tied to real work.
We’re hiring across many teams. If you’d like to join us, open roles are linked in the comments.
AI-native is a term a lot of companies use, but few can show you what it really looks like. Last week, the entire company shipped software: scientists, ops, clinicians, HR, marketing... many for the first time. Building on the data platform and tech stack our engineers have spent years developing, everyone was shipping practical tools in days.
AI is moving fast. Raising the floor on what every team can build, not just engineers, is how @formationbio is creating and leading the pharma company of the future. Link to our open roles in comments.
Applying validated biology to underexplored disease areas has produced some of medicine's most important therapies, but what's hard is doing it systematically – exhaustively following every evidence chain across every potential mechanism-indication pair.
We call this approach Known in New, and in our latest blog, we explore how Formation Bio is building the capability to do it at scale: https://t.co/PXGQGTYAxZ
AI-native is a term a lot of companies use, but few can show you what it really looks like. Last week, the entire company shipped software: scientists, ops, clinicians, HR, marketing... many for the first time. Building on the data platform and tech stack our engineers have spent years developing, everyone was shipping practical tools in days.
AI is moving fast. Raising the floor on what every team can build, not just engineers, is how @formationbio is creating and leading the pharma company of the future. Link to our open roles in comments.
we just added a bunch of new roles to our careers page, including in tech/marketing: https://t.co/yOMGZCFvQd
if you're a builder passionate about bio acceleration, DMs are open!
The best conversations happen with your running shoes on.
We're hosting @Techweek_ events in both Boston and New York this year, and we'd love for you to join us. We'll kick off with a 5k group run along the river (all paces welcome), then head back to our office for breakfast.
📍 Boston — May 27 along the Charles River: https://t.co/ia6pKd40ys
📍 New York — June 2 along the Hudson River Greenway: https://t.co/YXJzrg3hJN
More info and links to register above. #BOSTechWeek #NYTechWeek
Last week, Formation Bio CTO @dan_neil joined the @AWS Life Sciences Symposium reception panel alongside leaders from @Lux_Capital, @abbvie, and @AstraZeneca. With the conversation focused on innovation, Dan spoke about how one of the biggest bottlenecks facing drug development is actually organizational, and fixing this starts with how institutional knowledge is built and kept.
At Formation Bio, we build so that every program makes the next one smarter. Read more about Dan's thinking here: https://t.co/350DefUAWH
Great to see our CDO Gavin Corcoran in action on Monday at the Chief Medical Officer 360º Summit, by @FierceBiotech, exploring how we use AI to enhance clinical development. Gavin spoke about how real impact comes from AI systems that let you reimagine entire workflows, not just augment individual people within an old workflow.
Learn more about our approach: https://t.co/thPBVmN2QM
Our VP of Talent, Emily Gransky, joined The Biohub Podcast last week on AI-native talent strategy: from MCP-powered interview analysis to agentic recruiting workflows.
Full conversation and open roles linked below.
Last week, we hosted the Princeton Entrepreneurship Club for a Q&A with our CEO @BenjamineYLiu to discuss our founding story, approaching problem-solving with an entrepreneurial mindset, and what it takes to build and scale a company in the AI age.
Next week, our team will be at @PHUSE_Global US Connect in Austin to share insights on bridging the gap between AI demos and production-ready tools in clinical development, and the open-source innovations shaping the future of clinical data.
Learn more here: https://t.co/DH26pdb9bk
Our VP of Talent, Emily Gransky, recently joined The BioHub Podcast to discuss the talent acquisition strategy at Formation Bio — from values alignment in recruiting to AI’s current function in the talent space.
Links to the full conversation and open roles on our team are below.
Great humans train great AI, and our models learn from the best in the business. On @a16z's Raising Health podcast, our CEO @BenjamineYLiu shares how Formation Bio is building this generation’s AI-native pharma company – starting with a team that has a proven track record.
Link to full episode in the comments.